BioCentury
ARTICLE | Company News

Philogen, J&J deal

August 22, 2016 7:00 AM UTC

Philogen and Johnson & Johnson’s Janssen Biotech Inc. subsidiary partnered to discover and develop immunomodulatory therapeutics. The companies declined to disclose details. ...